Effects of transcutaneous auricular vagus nerve stimulation in individuals with primary dysmenorrhea.
Effects of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals with Primary Dysmenorrhea: A Randomized Controlled Trial.
AI Summary
Key Findings
Abstract
BACKGROUND AND AIMS: Transcutaneous auricular vagus nerve stimulation (taVNS) is a promising neuromodulation therapy with proved efficacy in treating various conditions, such as migraine, depression, abdominal pain, constipation, stroke, and sleep disorders. However, no randomized controlled trials have evaluated the effects of taVNS in patients with primary dysmenorrhea (PwPD). This study aims to investigate the impact of taVNS on pain, functional and emotional symptoms, and physical performance in PwPD. MATERIALS AND METHODS: In this study, conducted over two menstrual cycles, 34 PwPD were randomly assigned (1:1) to the taVNS or Sham groups. The treatment protocol comprised taVNS or sham treatment for five consecutive days, starting five days before the expected second menstrual period. The Numerical Rating Scale (NRS), pressure pain threshold (PPT), the Menstrual Symptom Questionnaire (MSQ), the Functional and Emotional Measure of Dysmenorrhea (FEMD), the Hamilton Anxiety Scale (HAM-A), and the 6-Minute Walking Test (6MWT) were evaluated at the first and subsequent menstrual cycles. RESULTS: The difference between the groups was significant, favoring the taVNS group in the NRS, PPT, MSQ, FEMD, HAM-A, and 6MWT (for all, p
Affiliation
Zeynep Yıldız Kızkın
External References
- PubMed ID:
- 41108303
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.